scispace - formally typeset
T

Takahiro Yamada

Researcher at Hokkaido University

Publications -  132
Citations -  7245

Takahiro Yamada is an academic researcher from Hokkaido University. The author has contributed to research in topics: Pregnancy & Proteinuria. The author has an hindex of 23, co-authored 125 publications receiving 6535 citations. Previous affiliations of Takahiro Yamada include Nagasaki University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells

TL;DR: E ectopic expression of Snail significantly reversed the inhibitory effects ofmiR-137 and miR-34a on OC cell invasion and sphere formation, and suggest that both miR -137 andMiR -34a act as Snail suppressors to negatively regulate EMT, invasive and sphere-forming properties of OC cells.
Journal ArticleDOI

Change in the number of patients after the adoption of IADPSG criteria for hyperglycemia during pregnancy in Japanese women

TL;DR: The IADPSG criteria increase the number of patients by at least 2.7-fold but may be cost-effective with respect to the resulting reduction in macrosomia.
Journal Article

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2459 more
- 01 Jan 2016 - 
Journal ArticleDOI

EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.

TL;DR: It is suggested that EZH2 drives EC progression by regulating miR-361/Twist signaling, and support EZh2 inhibition as a promising anti-EC therapeutic strategy.